BioCryst Pharmaceuticals
BCRX
BCRX
118 hedge funds and large institutions have $650M invested in BioCryst Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 37 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
118
Holding in Top 10
2
Calls
$5.65M
Puts
$5.65M
Top Buyers
| 1 | +$19.6M | |
| 2 | +$2.73M | |
| 3 | +$2.53M | |
| 4 |
Renaissance Technologies
New York
|
+$1.48M |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
+$1.24M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$8.07M | |
| 3 | -$5.59M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.68M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.09M |